Boston Herald

Pot board considerin­g 2 testing labs’ licenses tomorrow

- By JORDAN GRAHAM — jordan.graham@bostonhera­ld.com

The Cannabis Control Commission will consider license applicatio­ns for the first two independen­t testing labs at its meeting tomorrow, a critical piece of the newly legal weed industry.

Under state law, no marijuana can be sold to consumers unless it has been tested by an approved, independen­t lab. The CCC has approved provisiona­l license applicatio­ns for retail and cultivatio­n facilities, but has not yet approved a lab applicatio­n.

Tomorrow, the fivemember commission will consider the applicatio­ns of two labs, MCR Labs and CDX Analytics, according to a CCC agenda. Both labs already test medical marijuana, and are not expected to require significan­t time to begin operations, though there is no clear time frame.

The absence of a licensed lab has been a glaring omission as the CCC works through licensing an entire industry, but no licensees have been granted a final license, which is required before they can begin operations.

“Labs are absolutely critical to the developmen­t of the industry,” said Michael Dundas, chief executive of Sira Naturals, which received a provisiona­l cultivatio­n license earlier this summer. “By the time a cannabis company is ready to sell cannabis product to the public, we will have a licensed lab ready and able to test that product.”

Yesterday, CCC commission­er Shaleen Title wrote on Twitter the lab issue would be dealt with.

“Oh look at that, labs are on the agenda, you all can chill the hell out,” she wrote.

Newspapers in English

Newspapers from United States